First Genetic Hearing Loss Treatment Approved in the US, Available for Free
The Hidden Cause of Hearing Loss, Genetic Hearing Loss
Genetic hearing loss (hereditary hearing loss) is a condition where hearing cells are damaged, resulting in congenital hearing impairment. Existing treatments, such as hearing aids or cochlear implants, have limitations as they only alleviate symptoms.
Innovative Virus Delivery, AAV-Based Gene Therapy
The research team developed a gene therapy using adeno-associated virus (AAV) to correct defective genes. This vector accurately delivers the treatment to the inner ear (cochlea), demonstrating a mechanism to restore hearing cells.
First FDA Approval in the US, Free of Charge
In 2024, the US Food and Drug Administration (FDA) approved this treatment for the first time, and the government plans to cover the full cost, making it available for free. This provides a tangible lifeline for patients with genetic hearing loss.
A New Era in Hearing Treatment
In the future, more customized gene therapies for various genetic hearing disorders are expected to be developed. As this technology becomes a standard treatment, it is anticipated that the lives of millions of people with hearing loss will significantly improve.
First treatment for an inherited hearing disorder will be free in the United States
Patients with genetic hearing loss have struggled with irreversible hearing loss despite using traditional hearing aids. This free gene therapy will enable them to enjoy sounds in their daily lives again.